KSHV and the Role of Notch Receptor Dysregulation in Disease Progression
AbstractKaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of two human cancers, Kaposi’s Sarcoma (KS) and primary effusion lymphoma (PEL), and a lymphoproliferation, Multicentric Castleman’s Disease (MCD). Progression to tumor development in KS is dependent upon the reactivation of the virus from its latent state. We, and others, have shown that the Replication and transcriptional activator (Rta) protein is the only viral gene product that is necessary and sufficient for viral reactivation. To induce the reactivation and transcription of viral genes, Rta forms a complex with the cellular DNA binding component of the canonical Notch signaling pathway, recombination signal binding protein for Jk (RBP-Jk). Formation of this Rta:RBP-Jk complex is necessary for viral reactivation to occur. Expression of activated Notch has been shown to be dysregulated in KSHV infected cells and to be necessary for cell growth and disease progression. Studies into the involvement of activated Notch in viral reactivation have yielded varied results. In this paper, we review the current literature regarding Notch dysregulation by KSHV and its role in viral infection and cellular pathogenesis. View Full-Text
Share & Cite This Article
DeCotiis, J.L.; Lukac, D.M. KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens 2017, 6, 34.
DeCotiis JL, Lukac DM. KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens. 2017; 6(3):34.Chicago/Turabian Style
DeCotiis, Jennifer L.; Lukac, David M. 2017. "KSHV and the Role of Notch Receptor Dysregulation in Disease Progression." Pathogens 6, no. 3: 34.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.